Cholestyramine in type II hyperlipoproteinemia. A double-blind trial.
D000328:Adult; D000367:Age Factors; D001835:Body Weight; D002784:Cholesterol / Q000097:blood; D002791:Cholesterol, Dietary; D002792:Cholestyramine Resin / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy* / Q000235:genetics*; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000037:antagonists & inhibitors / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009765:Obesity; D010919:Placebos; D012737:Sex Factors; D014280:Triglycerides / Q000097:blood; D014973:Xanthomatosis / Q000188:drug therapy
D002791:Cholesterol, Dietary; D008055:Lipids; D008074:Lipoproteins; D010919:Placebos; D014280:Triglycerides; D002792:Cholestyramine Resin; D002784:Cholesterol